Zobrazeno 1 - 10
of 78
pro vyhledávání: '"van Maarseveen, E.M."'
Autor:
Punt, A.M., Stienstra, N.A., van Kleef, M.E.A., Lafeber, M., Spiering, W., Blankestijn, P.J., Bots, M.L., van Maarseveen, E.M.
Publikováno v:
In Journal of Chromatography B 15 July 2019 1121:103-110
Autor:
Sikma, M.A. *, van Maarseveen, E.M., van de Graaf, E.A., Kirkels, J.H., Verhaar, M.C., Donker, D.W., Kesecioglu, J., Meulenbelt, J.
Publikováno v:
In American Journal of Transplantation September 2015 15(9):2301-2313
Autor:
Bartelink, I.H., van Reij, E.M.L., Gerhardt, C.E., van Maarseveen, E.M., de Wildt, A., Versluys, B., Lindemans, C.A., Bierings, M.B., Boelens, Jaap Jan
Publikováno v:
In Biology of Blood and Marrow Transplantation March 2014 20(3):345-353
Autor:
Van Reij, E.M.L., Van Maarseveen, E.M., Egberts, A.C.G., Boelens, J.J., Rademaker, C.M.A., Sub Clinical Pharmacy, Pharmacoepi, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Pharmaceutisch Weekblad, 151(24), 25. Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP)
OBJECTIVE To assess target attainment of busulfan exposure using a new model-based dosing regimen and therapeutic drug monitoring (TDM). Busulfan is an alkylating drug used in conditioning regimens for allogeneic haematopoietic cell transplantation (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::eae7432c27b607525fccc37ec5f41016
https://dspace.library.uu.nl/handle/1874/428385
https://dspace.library.uu.nl/handle/1874/428385
Publikováno v:
Pharmaceutisch Weekblad, 151(24), 25. Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP)
OBJECTIVE To assess target attainment of busulfan exposure using a new model-based dosing regimen and therapeutic drug monitoring (TDM). Busulfan is an alkylating drug used in conditioning regimens for allogeneic haematopoietic cell transplantation (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0e77a60aeeab66510a54bb18e34ce9f5
https://dspace.library.uu.nl/handle/1874/350445
https://dspace.library.uu.nl/handle/1874/350445
Cyclophosphamide and vincristine are widely used intravenous chemotherapeutic agents in both human and veterinary oncology. Although intravenous administration of these chemotherapeutics is the gold standard in most treatment protocols, this route of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______101::6c43dc86e19b09ab79af77a35bfebf8c
https://dspace.library.uu.nl/handle/1874/322882
https://dspace.library.uu.nl/handle/1874/322882
Autor:
Langenhorst, J.B., van Kesteren, C., van Maarseveen, E.M., Dorlo, T.P.C., Nierkens, S., Lindemans, C.A., de Witte, M.A., van Rhenen, A., Raijmakers, R., Bierings, M., Kuball, J., Huitema, A.D.R., Boelens, J.J.
Publikováno v:
Blood Advances; July 2019, Vol. 3 Issue: 14 p2179-2187, 9p
Autor:
van Zeeland, Y.R.A., Schoemaker, N.J., Haritova, A., Smit, J.W., van Maarseveen, E.M., Lumeij, J.T., Fink-Gremmels, J., Advances in Veterinary Medicine, Risk Assessment of Toxic and Immunomodulatory Agents, Geneeskunde van gezelschapsdieren, Dep IRAS
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics, 36, 10.1111/j.1365. Blackwell Publishing Ltd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::17b8a1bf40b3c165fe0425ff86fae67b
https://dspace.library.uu.nl/handle/1874/273383
https://dspace.library.uu.nl/handle/1874/273383
Autor:
van Velzen, A.J., Uges, J.W.F., Heijerman, H.G.M., Arets, H.G., Nuijsink, M., van der Wiel-Kooij, E.C., van Maarseveen, E.M., van Zanten, G.A., Pullens, B., Touw, D.J., Janssens, H.M.
Publikováno v:
In Journal of Cystic Fibrosis June 2017 16 Supplement 1:S25-S26
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.